Corrigendum: Bruceine H mediates EGFR-TKI drug persistence in NSCLC by Notch3-dependent β-catenin activating FOXO3a signaling - Wu, Jiahui; He, Xiao; Xiong, Ziwei; Shi, Lingyu; Chen, Daofeng; Feng, Yulin; Wen, Quan (Frontiers in Oncology, 2024)